Your browser doesn't support javascript.
loading
Notoginsenoside R1 activates the Ang2/Tie2 pathway to promote angiogenesis.
Zhong, Jincheng; Lu, Weijin; Zhang, Jiayan; Huang, Maohua; Lyu, Wenyu; Ye, Geni; Deng, Lijuan; Chen, Minfeng; Yao, Nan; Li, Yong; Liu, Guanping; Liang, Yunfei; Fu, Jingwen; Zhang, Dongmei; Ye, Wencai.
Afiliación
  • Zhong J; College of Pharmacy, Jinan University, Guangzhou 510632, China; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research, Jinan University, Guangzhou 510632, China.
  • Lu W; College of Pharmacy, Jinan University, Guangzhou 510632, China; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research, Jinan University, Guangzhou 510632, China.
  • Zhang J; College of Pharmacy, Jinan University, Guangzhou 510632, China; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research, Jinan University, Guangzhou 510632, China.
  • Huang M; College of Pharmacy, Jinan University, Guangzhou 510632, China; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research, Jinan University, Guangzhou 510632, China.
  • Lyu W; College of Pharmacy, Jinan University, Guangzhou 510632, China.
  • Ye G; College of Pharmacy, Jinan University, Guangzhou 510632, China; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research, Jinan University, Guangzhou 510632, China.
  • Deng L; Formula­pattern Research Center, School of Traditional Chinese Medicine, Jinan University, Guangzhou 510632, China.
  • Chen M; College of Pharmacy, Jinan University, Guangzhou 510632, China; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research, Jinan University, Guangzhou 510632, China.
  • Yao N; College of Pharmacy, Jinan University, Guangzhou 510632, China; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research, Jinan University, Guangzhou 510632, China.
  • Li Y; College of Pharmacy, Jinan University, Guangzhou 510632, China; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research, Jinan University, Guangzhou 510632, China.
  • Liu G; Guangxi Engineering Research Center of Innovative Preparations for Natural Medicine, Guangxi Wuzhou Pharmaceutical (Group) Co., Ltd, Wuzhou 543000, China.
  • Liang Y; Guangxi Engineering Research Center of Innovative Preparations for Natural Medicine, Guangxi Wuzhou Pharmaceutical (Group) Co., Ltd, Wuzhou 543000, China.
  • Fu J; The Affiliated High School of South China Normal University, Guangzhou 510630, China.
  • Zhang D; College of Pharmacy, Jinan University, Guangzhou 510632, China; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research, Jinan University, Guangzhou 510632, China. Electronic address: dmzhang701@jnu.edu.cn.
  • Ye W; College of Pharmacy, Jinan University, Guangzhou 510632, China; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research, Jinan University, Guangzhou 510632, China. Electronic address: chywc@aliyun.com.
Phytomedicine ; 78: 153302, 2020 Nov.
Article en En | MEDLINE | ID: mdl-32823242

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neovascularización Fisiológica / Ginsenósidos / Receptor TIE-2 / Angiopoyetina 2 Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Phytomedicine Asunto de la revista: TERAPIAS COMPLEMENTARES Año: 2020 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neovascularización Fisiológica / Ginsenósidos / Receptor TIE-2 / Angiopoyetina 2 Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Phytomedicine Asunto de la revista: TERAPIAS COMPLEMENTARES Año: 2020 Tipo del documento: Article País de afiliación: China